US Patent Issued to Becton Dickinson and Co. on Sept. 8 for "Tissue-plasminogen activator coated catheter with hydrogel-controlled elution" (Utah Inventors)

ALEXANDRIA, Va., Sept. 8 -- United States Patent no. 12,728,185, issued on Sept. 8, was assigned to Becton Dickinson and Co. (Franklin Lakes, N.J.).

"Tissue-plasminogen activator coated catheter with hydrogel-controlled elution" was invented by Christopher Quach (North Salt Lake, Utah) and Dustin Payne (West Jordan, Utah).

According to the abstract* released by the U.S. Patent & Trademark Office: "A thrombo-resistant catheter includes a hydrogel coating containing a thrombolytic agent. The thrombolytic agent may be a lyophilized tissue plasminogen activator. The catheter has an intraluminal surface and an extraluminal surface, and the hydrogel coating is disposed on the intraluminal surface and/or the extraluminal surface. The hydrogel co...